Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: A novel antioxidative mechanism

Thrombosis and Haemostasis

Volumn 97, Issue 1, 2007, Pages 88-98

  Nascimento Silva, Vany ^a   Arruda, Maria Augusta ^a   Barja Fidalgo, Christina ^a   Fierro, Iolanda M ^a,b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Angiotensin; ATL; Cardiovascular disease; Lipoxin; NAD(P)H oxidase

Indexed keywords

ACETYLSALICYLIC ACID DERIVATIVE; ACETYLSALICYLIC ACID TRIGGERED LIPOXIN A4; ANGIOTENSIN 2 RECEPTOR; ANTIOXIDANT; DIHYDRORHODAMINE 123; HYDROETHIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTIOXIDANTS; ASPIRIN; CARDIOVASCULAR DISEASES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; LIPOXINS; NADPH OXIDASE; NF-KAPPA B; REACTIVE OXYGEN SPECIES;

EID: 33847004758     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-06-0315     Document Type: Article

References (44)

1. Serhan CN. Lipoxin and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 141-62.
2. Clària J, Serhan CN. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 1995; 92: 9475-9.
3. 4 and inhibits thromboxane in a randomized human trial. Proc Natl Acad Sci USA 2004; 101: 15178-83.
4. 4 stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors. J Exp Med 1997; 185: 1693-704.
5. 4 synthetic analog. J Immunol 2005; 175: 1843-50.
6. 4 stable analogs that block transmigration and adhesion of human PMN. Biochemistry 1995; 34: 14609-15.
7. Bannenberg G, Moussignac R, Gronert K, et al. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. Br J Pharmacol 2004; 143: 43-52.
8. 4 analogues with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo. J Med Chem 2004; 47: 2157-65.
9. Chiang N, Arita M, Serhan CN. Anti-inflammatory circuitry: lipoxin, Aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 163-77.
10. Serhan CN. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem Cell Biol 2004; 122: 305-21.
11. 4 levels. Exp Gerontol 2005; 40: 612-4.
12. Cai H, Griendling K, Harrison G. The vascular NAD(P)H oxidase as therapeutic targets in cardiovascular diseases. Trends in Pharmacol Sci 2003; 24: 471-8.
13. Griendling KK. Novel NAD(P)H oxidases in the cardiovascular system. Heart 2004; 90: 491-3.
14. Griendling KK, Sorescu D, Lassègue, B, et al. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000; 20: 2175-83.
15. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004; 122: 339-52.
16. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002; 90: 251-62.
17. 4 induces heme oxygenase-1 on endothelial cells. Am J Physiol Cell Physiol 2005; 289: C557-63.
18. 4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly. Oncogene 2005; 25: 122-9.
19. Petasis NA, Akritopoulou-Zanze I, Fokin VV, et al. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 301-21.
20. Parkinson JF. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation. Inflamm Allergy Drug Targets 2006; 5: 91-106.
21. Jaffe EA, Nachman RL, Becker CG et al. Culture of human endothelial cell derived from umbilical veins: identification by morphological criteria. J Clin Invest 1973; 52: 2745-56.
22. Galbusera M, Buelli S, Gastoldi S, et al. Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation. Xenotransplantation 2005; 12: 110-20.
23. Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 1994; 55: 253-8.
24. Garcia-Abreu J, Mendes FA, Onofre GR, et al. Contribution of heparan sulfate to the non-permissive role of the midline glia to the growth of midbrain neuritis. Glia 2000; 29: 260-72.
25. Krotz F, de Wit C, Sohn HY, et al. Magnetofection-a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol Ther 2003; 7: 700-10.
26. Coelho AL, De Freitas MS, Mariano-Oliveira A, et al. Interaction of disintegrins with human neutrophils induces cytoskeleton reorganization, focal adhesion kinase activation, and extracellular-regulated kinase-2 nuclear translocation, interfering with the chemotactic function. FASEB J 2001; 15: 1643-5.
27. Lassègue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression and regulation. Am J Physiol Regul Integr Comp Physiol 2003; 285: R277-97.
28. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501.
29. 4 with human neutrophils. J Biol Chem 1992; 267: 16168-76.
30. Gavins FN, Yona S, Kamal AM, et al. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 2003; 101: 4140-7.
31. Li JM, Shah AM. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 2002; 277: 19952-60.
32. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Eng J Med 1997; 336: 1066-71.
33. Fierro IM, Serhan CN. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins. Braz J Med Biol Res 2001; 34: 555-66.
34. Shen J, Herderick E, Cornhill JF, et al. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 1996; 98: 2201-8.
35. Shimbo D, Chaplin W, Crossman D, et al. Role of depression and inflammation in incident coronary heart disease events. Am J Cardiol 2005; 96: 1016-21.
36. Gonzalez ER. Antiplatelet therapy in atherosclerotic cardiovascular disease. Clin Ther 1998; 20 (Suppl B): B18-41.
37. Dragomir E, Manduteanu I, Voinea M, et al. Aspirin rectifies calcium homeostasis, decreases reactive oxygen species, and increases NO production in high glucose-exposed human endothelial cells. J Diabetes Complications 2004; 18: 289-99.
38. Levy BD, Petasis NA, Serhan CN. Polyisoprenyl phosphates in intracellular signalling. Nature 1997; 389: 985-90.
39. Chang TC, Huang CJ, Tam K, et al. Stabilization of hypoxia-inducible factor-1 a by prostacyclin under prolonged hypoxia via reducing reactive oxygen species level in endothelial cells. J Biol Chem 2005; 280: 36567-74.
40. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 2002; 397: 342-4.
41. Decoursey TE, Ligeti E. Regulation and termination of NADPH oxidase activity. Cell Mol Life Sci 2005; 62: 2173-93.
42. Paul-Clark MJ, Van Cao T, Moradi-Bidhendi N, et al. 15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J Exp Med 2004; 200: 69-78.
43. Kalinowski L, Malinski T. Endothelial NADH/NADPH-dependent enzymatic sources of superoxide production: relationship to endothelial dysfunction. Acta Biochimica Polonica 2004; 51: 459-69.
44. 4 might mediate heme oxygenase-1 induction by aspirin. Focus on "Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells". Am J Physiol Cell Physiol 2005; 289: C507-8.